Galectin-3 Performance in Histologic and Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis

Abstract

The literature on Galectin-3 (Gal-3) was systematically reviewed to achieve more robust information on its histologic reliability in identifying thyroid cancers and on the concordance between Gal-3 test in histologic and cytologic samples. A computer search of the PubMed and Scopus databases was conducted by combinations of the terms thyroid and Gal-3. Initially, 545 articles were found and, after their critical review, 52 original papers were finally included. They reported 8172 nodules with histologic evaluation of Gal-3, of which 358 with also preoperative FNAC Gal-3 assessment. At histology, Gal-3 sensitivity was 87% (95% confidence intervals [CI] from 86% to 88%), and specificity 87% (95% CI from 86% to 88%); in both cases, we found heterogeneity (I2 85% and 93%, respectively) and significant publication bias (p < 0.001). The pooled rate of positive Gal-3 at fine needle aspiration (FNAC) among cancers with histologically proven Gal-3 positivity was 94% (95% CI from 89% to 97%), with neither heterogeneity (I2 14.5%) nor bias (p = 0.086). These data show high reliability of Gal-3 for thyroid cancer at histology, while its sensitivity on FNAC samples is lower. The limits of cytologic preparations and interpretation of Gal-3 results have to be solved.

Aging‑associated genes TNFRSF12A and CHI3L1 contribute to thyroid cancer: An evidence for the involvement of hypoxia as a driver

“…TIMP-1, acts as an inhibitor for MMP9 expression that is often co-expressed with this molecule in thyroid tumors and serves as a reliable surrogate marker for BRAF-mutated status and likely aggressiveness (41). Notably, TIMP-1 serves as a prominent PPI hub gene in the Cytoscape network built upon co-expression of TNFRSF12A and CHI3L1, along with LGALS3, a specific biomarker of well-differentiated thyroid carcinomas (42), CXCL16, which mediated the involvement of macrophages in the invasion of papillary TCs (43) and fibronectin, an EMT biomarker which promoted migration and invasion of papillary thyroid cancers (44).…”

Glycosylation in the Thyroid Gland: Vital Aspects of Glycoprotein Function in Thyrocyte Physiology and Thyroid Disorders

“…Alterations of the glycan profile in TCs have been observed in thyroid tissue sections and in thyroid cells cultured in vitro. Moreover, the expression of galectins specific for β-galactose or LacNAc disaccharide was altered in TCs [ 100 , 101 ].…”

Comparison of Diagnostic Accuracy of Thyroid Cancer With Ultrasound-Guided Fine-Needle Aspiration and Core-Needle Biopsy: A Systematic Review and Meta-Analysis

“…Therefore, identifying parameters that may serve as potential markers of malignancy has a significant clinical value. Some of the molecular, cytological, ultrasound, and clinical studies investigated these parameters but yielded controversial results (7)(8)(9). Some recent studies reported that the microscopic histological examination of the core-needle biopsy (CNB) could diagnose a large number of uncertain thyroid nodules.…”